1. Home
  2. ABCL vs EFC Comparison

ABCL vs EFC Comparison

Compare ABCL & EFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • EFC
  • Stock Information
  • Founded
  • ABCL 2012
  • EFC 2007
  • Country
  • ABCL Canada
  • EFC United States
  • Employees
  • ABCL N/A
  • EFC N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • EFC Real Estate
  • Sector
  • ABCL Health Care
  • EFC Finance
  • Exchange
  • ABCL Nasdaq
  • EFC Nasdaq
  • Market Cap
  • ABCL 1.1B
  • EFC 1.2B
  • IPO Year
  • ABCL 2020
  • EFC 2010
  • Fundamental
  • Price
  • ABCL $4.72
  • EFC $13.18
  • Analyst Decision
  • ABCL Strong Buy
  • EFC Buy
  • Analyst Count
  • ABCL 5
  • EFC 5
  • Target Price
  • ABCL $8.75
  • EFC $14.30
  • AVG Volume (30 Days)
  • ABCL 6.8M
  • EFC 900.6K
  • Earning Date
  • ABCL 08-07-2025
  • EFC 08-07-2025
  • Dividend Yield
  • ABCL N/A
  • EFC 11.85%
  • EPS Growth
  • ABCL N/A
  • EFC 105.71
  • EPS
  • ABCL N/A
  • EFC 1.38
  • Revenue
  • ABCL $23,114,000.00
  • EFC $308,374,000.00
  • Revenue This Year
  • ABCL N/A
  • EFC N/A
  • Revenue Next Year
  • ABCL $71.11
  • EFC $12.52
  • P/E Ratio
  • ABCL N/A
  • EFC $9.52
  • Revenue Growth
  • ABCL N/A
  • EFC 26.77
  • 52 Week Low
  • ABCL $1.89
  • EFC $11.12
  • 52 Week High
  • ABCL $5.82
  • EFC $14.40
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 60.66
  • EFC 51.73
  • Support Level
  • ABCL $4.64
  • EFC $13.04
  • Resistance Level
  • ABCL $5.19
  • EFC $13.43
  • Average True Range (ATR)
  • ABCL 0.40
  • EFC 0.17
  • MACD
  • ABCL -0.01
  • EFC -0.02
  • Stochastic Oscillator
  • ABCL 43.84
  • EFC 32.05

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About EFC Ellington Financial Inc.

Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. it acquires reverse mortgage loans both through its origination activities and through secondary market purchases.

Share on Social Networks: